Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist, currently a principal scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology (IICB).

Ganguly graduated in medicine from Medical College and Hospital, Kolkata in 2001 but shifted his focus to biomedical research and joined the Institute of Genomics and Integrative Biology as a clinical associate.

[3] His post-doctoral work was at the Columbia University Medical Center as an SLE Foundation Fellow[4] and on his return to India, he joined IICB where he is currently a principal scientist.

Researchers from Ganguly Lab recently discovered a novel regulatory module involving the Piezo1 mechanosensors in human T cells, driven by mechanical cues.

[10] Ganguly lab also took interest in performing research on immunology of COVID-19 disease and ran a randomized control trial on convalescent plasma therapy.